23 Nov New diagnosis of multiple myeloma (NDMM) – Case
Author: Dr. Karla Machlab, MD, University of Toronto
Expert Reviewer: Dr. Anca Prica, MD, Staff Hematologist, Clinician Investigator, Princess Margaret Cancer Centre
After completion of this self-assessment module, the learner will be able to:
- Determine the best first line treatment for patients with NDMM.
- Determine the most appropriate maintenance therapy for patients with NDMM.
- Identify high-risk features associated with NDMM.
- Understand the role of tandem transplant in NDMM.
Accreditation: This activity is an Accredited Group Learning Activity (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of .25 hours.
The CHS Scientific Planning Committee has planned this case to achieve scientific integrity, objectivity and balance.
Scientific Planning Committee
Dr. Salima Ramdani – Resident Physician, Hematology
Dr. Pallavi Ganguli – Resident Physician, Hematology
Dr. Joanne Britto – Clinical Hematologist
Dr. Yan Xu – Clinical Hematologist, Hematology/Thrombosis
Dr. Siraj Mithoowani – Clinical Hematologist at St. Joseph’s Healthcare, Hamilton
Dr. Hassan Sibai – Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician, Division of Medical Hematology & Oncology, Princess Margaret Cancer Centre
Conflict of Interest: SPC and Author None